Living With Diffuse Large B-Cell Lymphoma (DLBCL)

This page is for people living with DLBCL and those who care for them. It covers infections, transfusions, how response and relapse are tracked, and getting through treatment day to day.

Diffuse large B-cell lymphoma, or DLBCL, is the most common type of non-Hodgkin lymphoma. It grows quickly. That sounds frightening, but it is also one of the more curable aggressive cancers when treated. Day-to-day life with DLBCL often means an intense but time-limited course of treatment, followed by careful checkups to watch for relapse (the cancer coming back).

Unlike slow-growing lymphomas, DLBCL almost always needs treatment right away. But fast growth also means DLBCL often responds quickly to chemotherapy. This is part of why a large share of people are cured with standard treatment. "Urgent" and "treatable" can feel strange to hold in mind at once, especially right after diagnosis.

Chemotherapy for DLBCL lowers your blood counts as part of how it works. That raises your infection risk during treatment. DLBCL can also directly affect the bone marrow, spleen, liver, or other organs in some cases. That adds to the risk. Ask your care team about handwashing, which vaccines are right for you, and when to call about anything that feels off.

Call your care team right away for a fever of 100.4°F or higher. This matters most in the days after a chemotherapy infusion, when your blood counts are typically at their lowest.

A red blood cell transfusion can treat the fatigue and shortness of breath of anemia. A platelet transfusion can lower your bleeding risk when platelets drop too low. These are routine, expected parts of chemotherapy for an aggressive lymphoma like DLBCL. They are not signs anything has gone wrong.

Doctors use imaging, often a PET scan, to check how your lymphoma is responding partway through treatment, and again afterward. This confirms whether treatment is working, and whether any lymphoma remains once your planned course is done.

Follow-up visits tend to be more frequent in the period right after treatment ends, then space out over time. Ask your team how long your closer-monitoring window lasts. Your team watches for new or growing lymph nodes, new symptoms, and changes on exams and, when needed, imaging.

Call your team for any of these:

• A fever of 100.4°F or higher
• A lymph node that returns or grows quickly
• Drenching night sweats
• Unexplained weight loss
• New shortness of breath

DLBCL treatment is often intense, but it usually has a defined end point, typically a set number of chemotherapy cycles over a few months. Knowing there is a finish line can help you get through the hardest stretches. Ask your team for the full planned schedule up front, so you can see the whole picture, not just the next appointment.

Once treatment finishes, many people feel a mix of relief and worry. The frequent appointments that once felt overwhelming may also have felt like safety. This is a common reaction. Regular follow-up visits continue, just spaced further apart, so you are not left without support once active treatment stops.

Chemotherapy cycles for DLBCL often bring a predictable rhythm: a hard stretch right after infusion, then gradual improvement before the next cycle starts. Eating what you can manage, drinking enough fluids, and resting during the hardest days can help. If eating becomes difficult, ask your team about anti-nausea medicine.

Ask what your treatment schedule looks like, including how chemotherapy cycles are spaced. Ask when your response will be checked with imaging. Ask how often you will need follow-up visits once treatment ends, and what would prompt an earlier one.

• National Cancer Institute — Adult Non-Hodgkin Lymphoma Treatment (PDQ).
• National Cancer Institute — Infections in People with Cancer.